Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates


Anaesthesia Critical Care & Pain Medicine
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le samedi 23 mars 2019
Doi : 10.1016/j.accpm.2019.03.004
CON: Levosimendan should be used in clinical practice for patients with significantly impaired left ventricular function undergoing cardiac surgery

Nick Fletcher a, b,
a St Georges Hospital NHS Trust, Blackshaw road, London SW17 0QT, London, UK 
b Cleveland Clinic, 33 Grosvenor Pl, Belgravia, London SW1X 7HY, London, UK 

Corresponding author: St Georges Hospital NHS Trust, Blackshaw road, London SW17 0QT, London, UKSt Georges Hospital NHS TrustBlackshaw road, London SW17 0QTLondonUK

Keywords : Levosimendan, Inotropes, Cardiac surgery

© 2019  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline